Tamar Thompson
Head of Global Corporate Affairs, Alexion, AstraZeneca Rare Disease
Tamar leads Global Corporate Affairs for Alexion, AstraZeneca Rare Disease. Her background spans the life sciences, managed care, and the provider segment. Previously, Tamar led Federal Executive Branch Strategy and State Government Affairs for Bristol-Myers Squibb. Mrs. Thompson also served as policy advisor and consultant at ADVI, Kimbell & Associates, and Avalere Health, managing a diverse life sciences clients. Mrs. Thompson developed and launched reimbursement and market access strategy for cutting-edge oncology therapeutic treatment options at Molecular Insight Pharmaceuticals (now Progenics) and has held leadership roles at GE Healthcare, Bracco Diagnostics, Humana, and ValueOptions (now Beacon Health Options).Tamar serves on the board of directors for Avidity Bioscience, MassBio, and Healthy Women, a patient empowerment organization. She also sits on the Schwartz Center (Mass General Hospital) Leadership Council. Tamar holds an M.S. in Health Sciences with a concentration in Public Health from Trident University in Cypress California; she has also received executive leadership certifications from Harvard University/School of Business, Columbia University Business School, and UC Berkeley.
